Search - tctmd.com

Displaying 381 - 400 of 421

Sort: Relevancy | Date

Presentation TCT 2013

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation TCT 2013

Insights into the Unique Capabilities of Bioabsorbable Polymer-based DES in High-risk Scenarios: 2-year Clinical and Imaging Data from COMFORTABLE AMI

Presenter: Lorenz Raber

October 27, 2013

Presentation TCT 2013

DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results

Presenter: Stefan Verheye

October 27, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

Presentation

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

Presenter: 53632|Koen Nieman

August 07, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

Presentation EuroPCR 2013

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Presenter: Alexandre Abizaid

May 21, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

Presentation TCT 2013

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye, Mark Webster, James Stewart, Alexandre Abizaid, RICARDO COSTA, Jose Costa Jr, John Yan, vinayak bhat, lynn morrison, Sara Toyloy, John Ormiston

January 31, 2013

News Daily News

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

November 27, 2012

Presentation TCT 2012

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Presenter: Yoshinobu Onuma

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presenter: Patrick Serruys

October 23, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Daily News

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

L.A. McKeown

July 05, 2012

News Daily News

DES Show More Neoatherosclerosis Than BMS Over 4 Years

L.A. McKeown

July 05, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

Advertisement

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Insights into the Unique Capabilities of Bioabsorbable Polymer-based DES in High-risk Scenarios: 2-year Clinical and Imaging Data from COMFORTABLE AMI

DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Los SLF Revelan Más Neoaterosclerosis que los SMD al cabo de 4 Años

DES Show More Neoatherosclerosis Than BMS Over 4 Years

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content